These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31545325)

  • 21. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.
    Chen W; Kumar AR; Hudson WA; Li Q; Wu B; Staggs RA; Lund EA; Sam TN; Kersey JH
    Cancer Cell; 2008 May; 13(5):432-40. PubMed ID: 18455126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic Analysis of Hematopoietic Stem and Progenitor Cell Populations in Acute Myeloid Leukemia Based on Spectral Flow Cytometry, a 20-Color Panel, and Unsupervised Learning Algorithms.
    Matthes T
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation.
    Heuts BMH; Arza-Apalategi S; Alkema SG; Tijchon E; Jussen L; Bergevoet SM; van der Reijden BA; Martens JHA
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
    Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O
    Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Liu J; Guo B; Chen Z; Wang N; Iacovino M; Cheng J; Roden C; Pan W; Khan S; Chen S; Kyba M; Fan R; Guo S; Lu J
    Blood; 2017 Mar; 129(11):1491-1502. PubMed ID: 28053194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
    Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
    PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Analysis of Mouse Hematopoietic Stem and Progenitor Cells.
    He L; Aouida A; Mehtar A; Haouas H; Louache F
    Methods Mol Biol; 2021; 2308():107-115. PubMed ID: 34057718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.
    Marlein CR; Zaitseva L; Piddock RE; Robinson SD; Edwards DR; Shafat MS; Zhou Z; Lawes M; Bowles KM; Rushworth SA
    Blood; 2017 Oct; 130(14):1649-1660. PubMed ID: 28733324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
    Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
    Tang C; Li MH; Chen YL; Sun HY; Liu SL; Zheng WW; Zhang MY; Li H; Fu W; Zhang WJ; Liang AB; Tang ZH; Hong DL; Zhou BS; Duan CW
    J Exp Clin Cancer Res; 2018 Aug; 37(1):204. PubMed ID: 30157922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
    Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The leukemia-associated Mll-Ell oncoprotein induces fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells.
    Shah CA; Bei L; Wang H; Platanias LC; Eklund EA
    J Biol Chem; 2013 Nov; 288(45):32490-32505. PubMed ID: 24089521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
    Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
    Johnson JJ; Chen W; Hudson W; Yao Q; Taylor M; Rabbitts TH; Kersey JH
    Blood; 2003 Apr; 101(8):3229-35. PubMed ID: 12515728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
    Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
    Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release.
    Golan K; Vagima Y; Ludin A; Itkin T; Cohen-Gur S; Kalinkovich A; Kollet O; Kim C; Schajnovitz A; Ovadya Y; Lapid K; Shivtiel S; Morris AJ; Ratajczak MZ; Lapidot T
    Blood; 2012 Mar; 119(11):2478-88. PubMed ID: 22279055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
    Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
    Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.